• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔鳞状细胞癌中 AKT1 和 PLK1 表达的临床病理意义。

Clinicopathological Significance of AKT1 and PLK1 Expression in Oral Squamous Cell Carcinoma.

机构信息

Department of Stomatology, Shihezi University School of Medicine & the First Affiliated Hospital to Shihezi University School of Medicine, Shihezi, 832002 Xinjiang, China.

Department of Pathology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University/Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu 225000, China.

出版信息

Dis Markers. 2022 Jun 17;2022:7300593. doi: 10.1155/2022/7300593. eCollection 2022.

DOI:10.1155/2022/7300593
PMID:35756492
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9232379/
Abstract

PURPOSE

Oral squamous cell carcinoma (OSCC) is the sixth leading cause of cancer-related death worldwide and is characterized by metastasis and recurrence. We aimed to evaluate the expression of AKT1 and PLK1 in OSCC and identify their correlation with the clinical and histological features and prognosis of patients with OSCC.

METHODS

Tissue samples were collected from 70 patients with OSCC and 50 patients with normal oral mucosa. The expression levels of AKT1 and PLK1 in OSCC tissues and normal oral mucosa were detected by immunohistochemistry. The chi-square test was used to identify correlations between the expression levels of AKT1 and PLK1 with patients' clinicopathologic characteristics. Survival analysis was assessed by the Kaplan-Meier method. Spearman's rank correlation test was used to determine the relationships between AKT1 and PLK1 expressions. The bioinformatics database GEPIA was used to verify the experimental results.

RESULTS

The chi-square test and Fisher's exact test showed that the positive expression rate of AKT1 and PLK1 in OSCC tissue was significantly higher than that in the normal oral mucosa ( < 0.05). PLK1 expression levels were significantly correlated with tumor stage and size ( < 0.05). Kaplan-Meier analysis showed that the survival time of AKT1 and PLK1 with high expression was significantly shorter than that of patients with low expression ( < 0.05). Spearman's rank correlation test showed a strong correlation between AKT1 and PLK1 expression in OSCC tissue ( = 0.53; < 0.05). GEPIA bioinformatics database analysis results show that the expression and overall survival of AKT1 and PLK1 analysis and the correlation analysis of AKT1 and PLK1 were consistent with experimental results.

CONCLUSION

AKT1 and PLK1 expressions are associated with the occurrence and progression of OSCC and may be used as diagnostic and prognostic indicators of OSCC. There may be a correlation between AKT1 and PLK1 in OSCC tissue.

摘要

目的

口腔鳞状细胞癌(OSCC)是全球第六大癌症相关死亡原因,其特征为转移和复发。我们旨在评估 AKT1 和 PLK1 在 OSCC 中的表达,并确定其与 OSCC 患者的临床和组织学特征及预后的相关性。

方法

收集 70 例 OSCC 患者和 50 例正常口腔黏膜患者的组织样本。采用免疫组织化学法检测 OSCC 组织和正常口腔黏膜中 AKT1 和 PLK1 的表达水平。采用卡方检验分析 AKT1 和 PLK1 表达水平与患者临床病理特征的相关性。采用 Kaplan-Meier 法评估生存分析。采用 Spearman 秩相关检验分析 AKT1 和 PLK1 表达之间的关系。采用生物信息学数据库 GEPIA 验证实验结果。

结果

卡方检验和 Fisher 确切检验显示,OSCC 组织中 AKT1 和 PLK1 的阳性表达率明显高于正常口腔黏膜( < 0.05)。PLK1 表达水平与肿瘤分期和大小显著相关( < 0.05)。Kaplan-Meier 分析显示,AKT1 和 PLK1 高表达患者的生存时间明显短于低表达患者( < 0.05)。Spearman 秩相关检验显示,OSCC 组织中 AKT1 和 PLK1 的表达呈强相关性( = 0.53; < 0.05)。GEPIA 生物信息学数据库分析结果显示,AKT1 和 PLK1 的表达分析及 AKT1 和 PLK1 的相关性分析与实验结果一致。

结论

AKT1 和 PLK1 的表达与 OSCC 的发生和进展有关,可能作为 OSCC 的诊断和预后指标。OSCC 组织中 AKT1 和 PLK1 之间可能存在相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc6/9232379/f328b5955cee/DM2022-7300593.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc6/9232379/511d47f963f7/DM2022-7300593.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc6/9232379/772a2fc5649b/DM2022-7300593.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc6/9232379/07a11158469a/DM2022-7300593.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc6/9232379/f328b5955cee/DM2022-7300593.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc6/9232379/511d47f963f7/DM2022-7300593.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc6/9232379/772a2fc5649b/DM2022-7300593.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc6/9232379/07a11158469a/DM2022-7300593.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc6/9232379/f328b5955cee/DM2022-7300593.004.jpg

相似文献

1
Clinicopathological Significance of AKT1 and PLK1 Expression in Oral Squamous Cell Carcinoma.口腔鳞状细胞癌中 AKT1 和 PLK1 表达的临床病理意义。
Dis Markers. 2022 Jun 17;2022:7300593. doi: 10.1155/2022/7300593. eCollection 2022.
2
Immunohistochemical expression of polo-like kinase 1 in oral squamous cell carcinoma and oral submucous fibrosis.polo样激酶1在口腔鳞状细胞癌和口腔黏膜下纤维化中的免疫组化表达
Indian J Dent Res. 2018 Mar-Apr;29(2):171-175. doi: 10.4103/ijdr.IJDR_59_17.
3
ER maleate is a novel anticancer agent in oral cancer: implications for cancer therapy.马来酸依那西普是口腔癌中的一种新型抗癌药物:对癌症治疗的意义。
Oncotarget. 2016 Mar 29;7(13):17162-81. doi: 10.18632/oncotarget.7751.
4
drug design and molecular docking studies targeting Akt1 (RAC-alpha serine/threonine-protein kinase) and Akt2 (RAC-beta serine/threonine-protein kinase) proteins and investigation of CYP (cytochrome P450) inhibitors against MAOB (monoamine oxidase B) for OSCC (oral squamous cell carcinoma) treatment.针对 Akt1(RAC-α丝氨酸/苏氨酸蛋白激酶)和 Akt2(RAC-β丝氨酸/苏氨酸蛋白激酶)蛋白的药物设计和分子对接研究,以及针对 MAOB(单胺氧化酶 B)的 CYP(细胞色素 P450)抑制剂对 OSCC(口腔鳞状细胞癌)治疗的研究。
J Biomol Struct Dyn. 2021 Oct;39(17):6467-6479. doi: 10.1080/07391102.2020.1802335. Epub 2020 Aug 4.
5
Clinical implications of heat shock protein 70 in oral carcinogenesis and prediction of progression and recurrence in oral squamous cell carcinoma patients: a retrospective clinicopathological study.热休克蛋白 70 在口腔癌发生中的临床意义及其对口腔鳞状细胞癌患者进展和复发的预测:一项回顾性临床病理研究。
Eur J Med Res. 2023 Oct 27;28(1):464. doi: 10.1186/s40001-023-01433-8.
6
Deregulation of hsa_circ_0001971/miR-186 and hsa_circ_0001874/miR-296 signaling pathways promotes the proliferation of oral squamous carcinoma cells by synergistically activating SHP2/PLK1 signals.hsa_circ_0001971/miR-186 和 hsa_circ_0001874/miR-296 信号通路的失调通过协同激活 SHP2/PLK1 信号促进口腔鳞状细胞癌细胞的增殖。
Sci Rep. 2021 Oct 18;11(1):20561. doi: 10.1038/s41598-021-99488-2.
7
Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.免疫组化检测 YAP 和 dNp63 以及癌前病变和口腔鳞状细胞癌患者的生存分析。
Int J Med Sci. 2019 May 28;16(5):766-773. doi: 10.7150/ijms.29995. eCollection 2019.
8
Prognostic significance of RKIP, TGM2, and CMTM4 expression in oral squamous cell carcinoma.RKIP、TGM2和CMTM4表达在口腔鳞状细胞癌中的预后意义
Medicine (Baltimore). 2024 Feb 16;103(7):e37278. doi: 10.1097/MD.0000000000037278.
9
Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.甲状旁腺激素相关蛋白作为口腔鳞状细胞癌的预后指标。
J Exp Clin Cancer Res. 2014 Dec 18;33(1):100. doi: 10.1186/s13046-014-0100-y.
10
Prognostic value of lymphatic vessel density in oral squamous cell carcinoma.口腔鳞状细胞癌中淋巴管密度的预后价值。
Life Sci. 2021 Jan 15;265:118746. doi: 10.1016/j.lfs.2020.118746. Epub 2020 Nov 9.

引用本文的文献

1
Exploring the role of PANoptosis related genes in the prognosis of oral squamous cell carcinoma subtypes based on multi-omics analysis.基于多组学分析探究PAN凋亡相关基因在口腔鳞状细胞癌亚型预后中的作用。
Discov Oncol. 2025 Jul 11;16(1):1305. doi: 10.1007/s12672-025-03154-2.
2
KIF2C promotes oral squamous cell carcinoma progression via PLK1 upregulation: implications for biomarker development and therapeutic targeting.KIF2C通过上调PLK1促进口腔鳞状细胞癌进展:对生物标志物开发和治疗靶点的启示
J Mol Histol. 2025 Apr 28;56(3):146. doi: 10.1007/s10735-025-10415-5.
3
Longikaurin A, a natural ent-kaurane, suppresses proliferation, invasion and tumorigenicity in oral squamous cell carcinoma cell by via inhibiting PI3K/Akt pathway and .

本文引用的文献

1
Changing Epidemiology of Oral Cavity Cancer in the United States.美国口腔癌的流行病学变化。
Otolaryngol Head Neck Surg. 2023 Apr;168(4):761-768. doi: 10.1177/01945998221098011. Epub 2023 Feb 5.
2
Targeting PI3K/Akt signal transduction for cancer therapy.针对 PI3K/Akt 信号转导通路的癌症治疗策略。
Signal Transduct Target Ther. 2021 Dec 16;6(1):425. doi: 10.1038/s41392-021-00828-5.
3
Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer.放疗作为一种揭示癌症中有临床意义的信号通路的工具。
龙卡灵A,一种天然的对映贝壳杉烷,通过抑制PI3K/Akt通路抑制口腔鳞状细胞癌细胞的增殖、侵袭和致瘤性。
J Cancer. 2025 Jan 1;16(3):708-719. doi: 10.7150/jca.102125. eCollection 2025.
4
Screening of Hub Genes and Therapeutic Drugs in Cervical Cancer Using Integrated Bioinformatics Analysis.基于综合生物信息学分析的宫颈癌关键基因及治疗药物筛选
J Cancer. 2025 Jan 1;16(1):92-109. doi: 10.7150/jca.87027. eCollection 2025.
5
CIP2A interacts with AKT1 to promote the malignant biological behaviors of oral squamous cell carcinoma by upregulating the GSK‑3β/β‑catenin pathway.CIP2A与AKT1相互作用,通过上调GSK‑3β/β‑连环蛋白信号通路来促进口腔鳞状细胞癌的恶性生物学行为。
Exp Ther Med. 2023 Sep 20;26(5):514. doi: 10.3892/etm.2023.12213. eCollection 2023 Nov.
6
Prognostic model based on telomere-related genes predicts the risk of oral squamous cell carcinoma.基于端粒相关基因的预后模型预测口腔鳞状细胞癌的风险。
BMC Oral Health. 2023 Jul 14;23(1):484. doi: 10.1186/s12903-023-03157-x.
7
MicroRNA-Based Markers of Oral Tongue Squamous Cell Carcinoma and Buccal Squamous Cell Carcinoma: A Systems Biology Approach.基于MicroRNA的口腔舌鳞状细胞癌和颊鳞状细胞癌标志物:一种系统生物学方法
Biochem Res Int. 2023 Apr 24;2023:5512894. doi: 10.1155/2023/5512894. eCollection 2023.
8
The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview.CD147 在口腔鳞状细胞癌发生发展中的多重作用:综述。
Int J Mol Sci. 2022 Jul 28;23(15):8336. doi: 10.3390/ijms23158336.
Nat Rev Clin Oncol. 2022 Feb;19(2):114-131. doi: 10.1038/s41571-021-00579-w. Epub 2021 Nov 24.
4
Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation.FBXO45 升高通过增强 IGF2BP1 泛素化和随后上调 PLK1 促进肝肿瘤发生。
Elife. 2021 Nov 15;10:e70715. doi: 10.7554/eLife.70715.
5
-Acting Factors Causing Secondary Epimutations: Impact on the Risk for Cancer and Other Diseases.导致继发性表观突变的作用因素:对癌症及其他疾病风险的影响
Cancers (Basel). 2021 Sep 26;13(19):4807. doi: 10.3390/cancers13194807.
6
Late phase 1 studies: concepts and outcomes.后期 1 期研究:概念和结果。
Lancet Oncol. 2021 Oct;22(10):e446-e455. doi: 10.1016/S1470-2045(21)00467-8.
7
Overview of Oral Potentially Malignant Disorders: From Risk Factors to Specific Therapies.口腔潜在恶性疾病概述:从危险因素到特定治疗方法
Cancers (Basel). 2021 Jul 23;13(15):3696. doi: 10.3390/cancers13153696.
8
Akt Isoforms: A Family Affair in Breast Cancer.Akt亚型:乳腺癌中的家族事务
Cancers (Basel). 2021 Jul 9;13(14):3445. doi: 10.3390/cancers13143445.
9
PARP1 and CHK1 coordinate PLK1 enzymatic activity during the DNA damage response to promote homologous recombination-mediated repair.PARP1 和 CHK1 在 DNA 损伤反应中协调 PLK1 的酶活性,以促进同源重组介导的修复。
Nucleic Acids Res. 2021 Jul 21;49(13):7554-7570. doi: 10.1093/nar/gkab584.
10
Modelling the Functions of Polo-Like Kinases in Mice and Their Applications as Cancer Targets with a Special Focus on Ovarian Cancer.模拟 Polo 样激酶在小鼠中的功能及其作为癌症靶点的应用,特别关注卵巢癌。
Cells. 2021 May 12;10(5):1176. doi: 10.3390/cells10051176.